## 



## 

## 

## 

||||||Pages|
|---|---|---|---|---|---|
|Report ofthe Chair|||||2-3|
|Report ofthe Trustees|||||4-14|
|Independent<br>Auditor's|Report||||15-20|
|Statement of Financial|Activities|(including|the Income and Expenditure|account)|21|
|Balance Sheet|||||22-23|
|Statement ofCash Flows|||||24|
|Notes to the Financial|Statements||||25-36|





## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 



## 

## 



## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 



## 

## 

## 

## 



## 



## 

|AR ENDED 31MARCH 2|021||||||
|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total funds|Total funds|
|||Note|Income Fund|Income|2021|2020|
|||||Fund|||
|Income and endowments|from:||||||
|Donations<br>and legacies|||514,023|205,819|719,842|738,879|
|Activities for generating|funds||139,360||139,360|197,532|
|Investments|||1,318||1,318|7,754|
|Other|||43,075||43,075||
|Total income and endowments|||697,776|205,819|903,595|944,165|
|Expenditure<br>on:|||||||
|Raising funds||8|188,482||188,482|209,398|
|Charitable<br>activities||8|271,706|267,061|538,767|997,084|
|Total expenditure||8|460,188|267,061|727,249|1,206,482|
|Net gains/(losses)<br>on investments|||252,627||252,627|(2,397)|
|Net income/(expenditure)|||490,215|(61,242)|428,973|(264,714)|
|Transfers between funds|||||||
|Net movement<br>in funds|||490,215|(61,242)|428,973|(264,714)|
|Reconciliation offunds:|||||||
|Total Funds at 31March|2020||1,373,476|305,952|1,679,428|1,944,142|
|Total funds at 31March|2021||1,863,691|244,710|2,108,401|1,679,428|





## 

## 

## 

## 

|LANCE SHEE<br>31MARCH|T<br> 2021|||||Company|number: 07|302036|
|---|---|---|---|---|---|---|---|---|
||||||Unrestricted|Restricted|Total|Total|
|||||Note|Income|income|funds|funds|
||||||Fund|Fund|2021|2020|
|Fixed assets|||||||||
|Tangible assets||||12|10,244||10,244|9,999|
|Investments||||13|1,431,717|896,679|2,328,396|2,074,556|
||||||1,441,961|896,679|2,338,640|2,084,555|
|Current assets|||||||||
|Stocks||||14|7,570||7,570|8,228|
|Debtors||||15|243,209||243,209|197,351|
|Cash at bank|and in|hand||16|191,470||191,470|221,710|
||||||442 249||442 249|427 289|
|Liabilities:|||||||||
|Creditors: Amounts||falling due within one||17|(20,519)|(421,998)|(442,517)|(337,418)|
|year|||||||||
|Net current|assets/(liabilities)||||421,730|(421,998)|(268)|89,871|
|Total assets|less current||liabilities||1,863,691|474,681|2,338,372|2,174,426|
|Creditors: Amounts||falling due after more||18||(229,971)|(229,971)|(494,998)|
|than one year|||||||||
|Net assets/(liabilities)|||||1,863,691|244,710|2,108,401|1,679,428|
|Charity Funds|||||||||
|Unrestricted|funds||||1,609,851||1,609,851|1,228,622|
|Revaluation|reserve||||253,840||253,840|144,854|
|Restricted funds||||23||244,710|244,710|305,952|
|Total charity|funds||||1,863,691|244,710|2,108,401|1,679,428|





## 

## 

|AR ENDED 31MARCH 20|21|||||
|---|---|---|---|---|---|
|||||Total funds|Total funds|
||||Note|2021|2020|
|||||E|E|
|Cash flow from operating|activities||19|(26,612)|(68,452)|
|Cash flow from investing|activities|||||
|interest<br>received||||1,318|7,754|
|Payments to acquire oftangible fixed assets||||(3,777)|(2,364)|
|Receipts from sales oftangible assets||||44||
|Payments to acquire investments||||(301,213)|(232,543)|
|Receipts from sale of investments||||300,000|375,000|
|Net cash flow from investing<br>activities||||(3,628)|147,847|
|Change<br>in cash and cash|equivalents|||(30,240)|79,395|
|Cash and cash equivalents|brought|forward||221,710|142,315|
|Cash and cash equivalents|carried|forward||191,470|221,710|
|Cash and cash equivalents|consist|of:||||
|Cash at bank and in hand||||191,470|221,710|
|Short term deposits||||||
|Cash and cash equivalents|at 31March 2021|||191,470|221,710|





## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

|useful economic life as f|ollows:|ollows:||
|---|---|---|---|
|Asset class|Depreciation||method<br>and rate|
|Office equipment|Straight|line|over 5years|
|Patient aids|Straight|line|over 5years|



## 

## 

## 



## 

## 

## 

## 

|Income|from donations<br>and legacies|||||
|---|---|---|---|---|---|
|||Unrestricted|Restricted|Total|Total|
|||Income|Income|2021|2020|
|||Fund|Fund|||
|||E|E|f|E|
|Donations|and legacies|||||
|Donations|under the Gift Aid scheme|60,389||60,389|39,103|
|Legacy donations||55,261||55,261|186,546|
|Memoriam|donations|143,210|27,395|170,605|121,873|
|Other donations||255,163|178,424|433,587|391,357|
|||514,023|205,819|719,842|738,879|





## 

## 

## 

|Income from activities for ge|nerating<br>funds||||
|---|---|---|---|---|
||Unrestricted|Restricted|Total|Total|
||Income|Income|2021|2020|
||Fund|Fund|||
||E|E|E|E|
|Event income|127,186||127,186|182,028|
|Merchandise|12,174||12,174|15,504|
||139,360||139,360|197,532|



|||||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|---|---|---|
|||||||Income|Income|2021|2020|
|||||||Fund|Fund|||
|||||||E|E|E|E|
|Interest|receivable|from|UK|deposit|account|1,318||1,318|7,754|
|||||||1,318||1,318|7,754|



||||Unrestricted|Restricted|Total|Total|
|---|---|---|---|---|---|---|
||||Income|Income|2021|2020|
||||Fund|Fund|||
||||||E|E|
|)ob|retention|scheme|43,075||43,075||
||||43,075||43,075||



|Net inco|me/(|expenditure)<br>and n|et movements<br>in funds have|been stated after charging:||
|---|---|---|---|---|---|
|||||Total|Total|
|||||2021|2020|
|||||E|E|
|Depreciation|of|tangible fixed assets||3,488|2,918|
|(Profit)/loss|on|fair value movement|ofinvestments|(252,627)|2,397|





## 

## 

## 

|Analysis ofreso|urces expended|||
|---|---|---|---|
|||Total|Total|
|||2021|2020|
|Cost ofgenerating|funds|||
|Merchandise||3,822|1,570|
|Events and catering||1,673|6,184|
|Salaries||96,248|88,591|
|PR and Marketing||3,912|4,337|
|Support costs||82,826|108,716|
|||188,482|209,398|



|tricted<br>fun|ds was 6 nil (2020 —6 nil).|||||
|---|---|---|---|---|---|
|||Direct|Support|Total|Total|
|||activities|costs|2021|2020|
||||E|E|f|
|Charitable|activities|||||
|Research||106,669|13,177|119,846|568,815|
|Info and patient support||326,684|92,237|418,921|428,269|
|||433,353|105,414|538,767|997,084|



## 

||||Cost of|Research|Info and|Total|
|---|---|---|---|---|---|---|
||||generating||patient||
||||funds||support||
||||||f||
|Bookkeeping|and administration|fees|1,641|261|1,827|3,729|
|Rent|||13,255|2,109|14,762|30,126|
|Office costs|||41,140|6,545|45,814|93,499|
|Sundry|||524|83|584|1,191|
|Governance|costs (see note 9)||26,266|4,179|29,250|59,695|
||||82,826|13,177|92,237|188,240|





## 

## 

## 

||||Total|Total|
|---|---|---|---|---|
||||2021|2020|
||||E|E|
|Auditor's|remuneration||3,888|3,744|
|Accountancy||fees|2,932|5,869|
|Professional||fees|25,385|32,288|
|Salaries|||27,480|28,455|
|Trustees'|meetings||10|263|
||||59,695|70,619|



||||Grants to|Direct|Support|Total|
|---|---|---|---|---|---|---|
||||Institutions|costs|costs||
||||E|E|||
|Dr|V|Chelban|64,322|||64,322|
||||64,322|||64,322|



## 

|e average number of pe|rsons<br>employed<br>by the charity during|the year was:||
|---|---|---|---|
|||Total|Total|
|||2021|2020|
|Office staff||||
|Specialist nurses||||
|Advocacy Officer/Social|Welfare Specialist|||
|||13||





## 

|. Staff costs (continued)|||
|---|---|---|
||Total|Total|
||2021|2020|
||E|E|
|Gross wages|410,979|392,558|
|Social security|34,480|34,353|
|Pension costs|18,321|19,318|
||463,780|446,229|



|12.Tangible|fixed assets|Office|Patient|Total|
|---|---|---|---|---|
|||equipment|Aids||
|Cost or valuation|||||
|At April 2020||19,277|57,577|76,854|
|Additions||3,777||3,777|
|Disposals||(289)||(289)|
|At 31March|2021|22,765|57,577|80,342|
|Depreciation|||||
|At April 2020||14,833|52,022|66,855|
|Charge for the year||1,778|1,710|3,488|
|Elimination|on disposal|(245)||(245)|
|At 31March|2021|16,366|53,732|70,098|
|Net BookValue|||||
|At 31March|2021|6,399|3,845|10,244|
|At 31March|2020|4,444|5,555|9,999|





## 

## 

## 

|13.Investments|13.Investments|||Total||
|---|---|---|---|---|---|
|||||2021||
|Cost or valuation||||E||
|At 1April 2020||||2,074,556||
|Additions||||301,213||
|Disposals||||(300,000)||
|Revaluation||||252,627||
|At 31March|2021|||2,328,396||
|Impairment||||||
|At 1April 2020 and||31March 2021||||
|Carrying amount||||||
|At 31March|2021|||2,328,396||
|At 31March|2020|||2,074;556||
||||||Market|
|||||Cost|Value|
|||||31March|31March|
|||||2021|2021|
|The Trustees'|investments||were made up as|f|E|
|follows:||||||
|CCLA||||1,986,180|2,328,396|
|||||1,986,180|2,328,396|
|||||31March|31March|
|||||2021|2020|
|Investments|at fair value||comprise:|E|E|
|Equities||||1,009,918|1,057,291|
|Cash with investment||portfolio||1,318,478|1,017,265|
|||||2,328,396|2,074,556|





## 

## 

|14.Stock|||||||
|---|---|---|---|---|---|---|
||||||2021|2020|
|Finished goods:|Merchandise||||7,570|8,228|
|15.Debtors|||||||
||||||2021|2020|
||||||f|E|
|Trade debtors|||||||
|Other debtors|||||44,993|24,684|
|Accrued income|||||198,216|172,667|
||||||243,209|197,351|
|16.Cash at bank|||||||
||||Unrestricted|Restricted|Total|Total|
||||income|income|funds|funds|
||||funds|funds|2021|2020|
|||||E|E||
|Cash committed|for|research grant funding|||||
|Other cash|||191,470||191,470|221,710|
||||191,470||191,470|221,710|
|17.Creditors: amounts||falling due within one year|||||
||||||2021|2020|
||||||E|E|
|Accrual for Research||grants|||421,998|313,427|
|Other taxation|and social security||||10,159|9,321|
|Other creditors|||||10,360|14,670|
||||||442,517|337,418|





## 

|2021|2020|
|---|---|
|E|E|
|229,971|494,998|



|.<br>Reconciliat|ion<br>o|f net move|ment<br>in funds to net cash flo|w from operating<br>activities||
|---|---|---|---|---|---|
|||||Total|Total|
|||||funds|funds|
|||||2021|2020|
|||||E|E|
|Movement<br>in|net funds|||428,973|(264,714)|
|Depreciation|oftangible fixed||assets|3,488|2,918|
|Interest receivable||||(1,318)|(7,754)|
|(Gains)/losses|on investments|||(252,627)|2,397|
|Decrease/(Increase)||in stocks||658|(5 157)|
|Decrease/(Increase)||in debtors||(45,858)|(41,398)|
|Increase/(Decrease)||in creditors||(159,928)|245,256|
|Net cash flow|from|operating|activities|(26,612)|(68,452)|



## 

||||Total|Total|
|---|---|---|---|---|
||||funds|funds|
||||2021|2020|
|Within|one|year|2,404|5,019|
|Within|one|to five years|7,724|10,129|
||||10,128|15,148|





## 

## 

||||Research|Nurse|Regional|Other|Total|Total|
|---|---|---|---|---|---|---|---|---|
|||||specialists|Core||2021|2020|
|||||||E|E||
|Brought forward||funds|305,952||||305,952|806,956|
|Income arising|in the year||3,080|104,245|71,929|26,565|205,819|136,455|
|Expenses paid|during the year||(64,322)|(104,245)|(71,929)|(26,565)|(267,061)|(637,459)|
|Carried forward||funds|244,710||||244,710|305,952|



## 

|.Analysis o|ffunds|||||||
|---|---|---|---|---|---|---|---|
||||At 1April|Incoming|Resources|Gains|At 31|
||||2020|resources|expended|encl|March|
|||||||losses|2021|
||||E|E|E|||
|Analysis of|movements|in funds||||||
|Unrestricted|fund||1,373,476|697,776|(460,188)|252,627|1,863,691|
|Restricted fund|||305,952|205,819|(267,061)||244,710|





## 

|||Fixed|Net|Non-|Total|
|---|---|---|---|---|---|
|||assets|current|current||
||||assets|creditors||
|||||E|f|
|Unrestricted|fund|1,441,961|421,730||1,863,691|
|Restricted fund||896,679|(421,998)|(229,971)|244,710|
|||2,338,640|(268)|(229,971)|2,108,401|



## 

|tially<br>recognised<br>at transaction<br>value and subsequ|ently<br>measured<br>at their amortised cost.||
|---|---|---|
|Financial assets|2021|2020|
|Trade debtors|||
|Other debtors|44,993|24,684|
||44,993|24,684|
|Financial liabilities|2021|2020|
|Research grants|651,969|808,425|
|Other creditors|20,519|23,991|
||672,488|832,416|



|Financial assets|2021|2020|
|---|---|---|
||E||
|Investments|2,328,396|2,074,556|